fundvisualizer.com

Vanguard Value Index InvVIVAX

Performance (before sales charge)

As of 08/31/2022

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 08/31/2022
Stock
98.74%
Non-U.S. Stock
0.77%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.49%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 08/31/2022

Basic materials

2.70%

Consumer cyclical

2.57%

Financial services

19.74%

Real estate

3.29%

Consumer defensive

11.48%

Health care

21.35%

Utilities

6.28%

Communication services

3.58%

Energy

8.18%

Industrials

12.24%

Technology

8.10%

Top 10 holdings

As of 08/31/2022

UnitedHealth Group Inc
2.96%
Berkshire Hathaway Inc Class B
2.95%
Johnson & Johnson
2.58%
Exxon Mobil Corp
2.45%
JPMorgan Chase & Co
2.03%
Procter & Gamble Co
2.01%
Chevron Corp
1.70%
Eli Lilly and Co
1.57%
Pfizer Inc
1.54%
Coca-Cola Co
1.46%
Fund assets

$143.39 Billion

Share class

Inv

Morningstar category

Large Value

Expense ratio

0.17%

Investment objective

Growth

Documents